Not a Wheelchair

The conversation centers around the high costs of custom-fit lightweight wheelchairs, with one commenter stating, "What Zack and Cambry are doing is great." Participants highlight the potential for lower prices if regulatory hurdles like FDA approval are bypassed.

Another recurring theme in the discussion is the importance of safety and regulation in wheelchair manufacturing. Another user notes, "I would not consider sidestepping FDA in order to ethically and legally answer for all of those risks," emphasizing the need for rigorous safety standards despite the appeal of affordability.